Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis ; volume:34 ; number:2 ; day:6 ; month:1 ; year:2024 ; pages:303-309 ; date:2.2024
Obesity surgery ; 34, Heft 2 (6.1.2024), 303-309, 2.2024

Creator: Vinciguerra, Federica
Di Stefano, Carla
Baratta, Roberto
Pulvirenti, Alfredo
Mastrandrea, Giuseppe
Piazza, Luigi
Guccione, Fabio
Navarra, Giuseppe
Frittitta, Lucia

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11695-023-07053-9

URN: urn:nbn:de:101:1-2024040511292354625233

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Vinciguerra, Federica
Di Stefano, Carla
Baratta, Roberto
Pulvirenti, Alfredo
Mastrandrea, Giuseppe
Piazza, Luigi
Guccione, Fabio
Navarra, Giuseppe
Frittitta, Lucia
SpringerLink (Online service)

Other Objects (12)

Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery

The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery

Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting

Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

High-dose Methotrexate

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)

Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery

The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery

Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting

Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

High-dose Methotrexate

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)

Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery

The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery

Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting

Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

High-dose Methotrexate

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery

The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery

Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting

Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

High-dose Methotrexate

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)

Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery

The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery

Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting

Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

High-dose Methotrexate

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)

Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery

The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery

Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting

Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

High-dose Methotrexate

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)

Related objects

Reset password